Search

Structure-based computational approach for optimizing oligonucleotides for A-to-I editing

Poster

Applicability of a structure-based modelling approach as a tool for in silico screening of oligonucleotides for targeted RNA editing presented at Oligonucleotide Therapeutics Society (OTS) 2018 by Julien Boudet

September 30, 2018
ProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology

Press release

Key updates

September 21, 2017
ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update

Press release

Key updates

February 28, 2017
ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences

Press release

LEIDEN, Netherlands, Oct. 1, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

October 01, 2015
ProQR to Present at Scientific and Investor Conferences in September

Press release

LEIDEN, the Netherlands, Sept. 06, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

September 06, 2016
ProQR Announces Presentations at the OTS Annual Meeting

Press release

LEIDEN, the Netherlands, Sept. 24, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

September 24, 2018
ProQR Announces Financial Results for the Third Quarter of 2018

Press release

LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

November 07, 2018
ProQR Announces Results for the Third Quarter of 2016

Press release

LEIDEN, the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

November 14, 2016
ProQR Announces Results for the Third Quarter of 2017

Press release

… interim data also expected in 2018. Spin-out of Amylon Therapeutics as a privately-held company focused on central … Axiomer ® RNA editing technology platform at the Oligonucleotide Therapeutics Society (OTS) meeting in Bordeaux, France and at the Drug …

November 20, 2017